Search Tag: contrast-enhanced mammography
2025 24 Aug
Contrast-enhanced mammography (CEM) is gaining clinical traction as a cost-effective imaging technique with diagnostic performance comparable to MRI. Since its commercial debut in 2011, global uptake has increased, yet reimbursement mechanisms remain fragmented and inconsistent. An international survey among CEM expert centres highlights this disparity,...Read more
2025 24 Aug
Contrast-enhanced mammography (CEM) is gaining clinical traction as a cost-effective imaging technique with diagnostic performance comparable to MRI. Since its commercial debut in 2011, global uptake has increased, yet reimbursement mechanisms remain fragmented and inconsistent. An international survey among CEM expert centres highlights this disparity,...Read more
2025 24 Aug
Contrast-enhanced mammography (CEM) is gaining clinical traction as a cost-effective imaging technique with diagnostic performance comparable to MRI. Since its commercial debut in 2011, global uptake has increased, yet reimbursement mechanisms remain fragmented and inconsistent. An international survey among CEM expert centres highlights this disparity,...Read more
2025 24 Aug
Contrast-enhanced mammography (CEM) is gaining clinical traction as a cost-effective imaging technique with diagnostic performance comparable to MRI. Since its commercial debut in 2011, global uptake has increased, yet reimbursement mechanisms remain fragmented and inconsistent. An international survey among CEM expert centres highlights this disparity,...Read more
2025 13 Aug
Contrast-enhanced mammography (CEM) is gaining prominence as an important technique for detecting and diagnosing breast cancer, offering both morphological and physiological information in a single examination. By combining low-energy mammographic images with recombined high-energy images following the administration of iodinated contrast medium,...Read more
2025 13 Aug
Contrast-enhanced mammography (CEM) is gaining prominence as an important technique for detecting and diagnosing breast cancer, offering both morphological and physiological information in a single examination. By combining low-energy mammographic images with recombined high-energy images following the administration of iodinated contrast medium,...Read more
2025 14 Apr
Contrast-enhanced mammography (CEM) is a functional imaging technique that integrates anatomical and vascular information to aid in the detection of breast lesions. By administering intravenous contrast and using dual-energy acquisition methods, CEM enhances the visualisation of abnormal tissue, particularly in individuals with dense breast tissue....Read more
2024 08 Sep
Breast cancer screening is a crucial public health initiative aimed at early detection of breast malignancies. In many countries, including the Netherlands, mammography is a primary screening tool. Women recalled after an abnormal screening face additional imaging and diagnostic procedures, often increasing anxiety and healthcare costs. Contrast-enhanced...Read more
2024 11 Apr
Bayer and Hologic, Inc . announced a first-of-its-kind collaboration to deliver a coordinated solution for contrast-enhanced mammography (CEM). The two companies will showcase the solution at the annual Society of Breast Imaging Symposium from April 11-14, 2024 in Montreal, Canada. Contrast-enhanced mammography is a sensitive and relatively...Read more
2024 11 Apr
Bayer and Hologic, Inc . announced a first-of-its-kind collaboration to deliver a coordinated solution for contrast-enhanced mammography (CEM). The two companies will showcase the solution at the annual Society of Breast Imaging Symposium from April 11-14, 2024 in Montreal, Canada. Contrast-enhanced mammography is a sensitive and relatively...Read more